title: [Summarizing of medicinal alerts in Ivory Coast from 2001 till 2010].
abstract: STUDY'S AIM: This study aims a more efficient follow-up of the safety of medicines with human usage on the Ivory Coast territory.
  
  
  METHODS
  The structure responsible for pharmacovigilance in Ivory Coast i.e. DPM listed the medicinal alerts from 2001 till 2010.
  
  
  RESULTS
  It emerges 237 medicinal alerts among which 145 stops of marketing, 55 withdrawals of lots, 33 information notes and 4 levying of suspension of medicines. These alerts result mainly from pharmaceutical companies (49%) and the French Drug Agency or ANSM (ex-Afssaps) (43%). They mainly concern drugs of infectious target (22%) and pneumology (18%) and their motivations are so much industrial with mainly commercial reasons (27%) as of pharmacovigilance dominated by unfavorable profit/risk connections.
  
  
  CONCLUSIONS
  These results constitute an important database for the survey of the medicines market in Ivory Coast and an additional motivation to accelerate the implementation of a real national center of pharmacovigilance.
authors.affiliation: Direction de la Pharmacie et du Médicament, Abidjan, Côte d'Ivoire. jemigrace@gmail.com
authors.forename: Amenan Geneviève
authors.initials: AG
authors.lastname: N'Guessan-Irié
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Yavo
authors.forename: Antoine Serge
authors.initials: AS
authors.lastname: Guillaume Amari
authors.forename: Ange Désiré
authors.initials: AD
authors.lastname: Yapi
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000458:organization & administration* / Q000706:statistics & numerical data / Q000639:trends; D007560:Cote d'Ivoire / Q000453:epidemiology; D016208:Databases, Factual; D004345:Drug Industry / Q000191:economics / Q000706:statistics & numerical data; D064420:Drug-Related Side Effects and Adverse Reactions / Q000191:economics / Q000453:epidemiology*; D005602:France; D006801:Humans; D008389:Marketing of Health Services / Q000191:economics / Q000706:statistics & numerical data; D060735:Pharmacovigilance; D057051:Product Recalls and Withdrawals; D011358:Product Surveillance, Postmarketing; D018570:Risk Assessment